Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Allegri

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 4, 2020
Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging InitiativeRicardo F Allegri, Patricio Chrem Méndez, Ismael Calandri, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2018
Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment GroupFernando E Taragano, Ricardo F Allegri, Silvina L Heisecke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Argentina-Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional AdvancementJonathan Fernando Cubas Guillen, Patricio Chrem Méndez, Ezequiel Surace, et al.
Scandinavian Journal of Rheumatology|February 9, 2000
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLEG D Sebastiani, M Galeazzi, A Tincani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 6, 2024
Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core datasetJames E Galvin, Jeffrey L Cummings, Mihaela Levitchi Benea, et al.
Brain Pathology (Zurich, Switzerland)|January 7, 2026
Frontotemporal dementia: Clinical aspects, genetics, and neuropathology of a family with a C9ORF72 expansion in ArgentinaKaren Daniela Román, Carolina Agata Ardohain, Ezequiel I Surace, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2024
Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidanceLeanne Howard, Carla Abdelnour, Erin L Abner, et al.
Lupus|March 14, 2000
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusM Galeazzi, G D Sebastiani, A Tincani, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Etiologies of rapidly progressive dementias: A systematic review and meta-analysis of causes in worldwide and Latin AmericaJonathan Fernando Cubas Guillen, Carolina Agata Ardohain Cristalli, Waleska Berrios, et al.
Medicina|February 12, 2020
[Multidisciplinary rehabilitation for adult patients with stroke]Lucas Alessandro, Lisandro E Olmos, Lucas Bonamico, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 4, 2020
Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging InitiativeRicardo F Allegri, Patricio Chrem Méndez, Ismael Calandri, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2018
Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment GroupFernando E Taragano, Ricardo F Allegri, Silvina L Heisecke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Argentina-Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional AdvancementJonathan Fernando Cubas Guillen, Patricio Chrem Méndez, Ezequiel Surace, et al.
Scandinavian Journal of Rheumatology|February 9, 2000
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLEG D Sebastiani, M Galeazzi, A Tincani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 6, 2024
Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core datasetJames E Galvin, Jeffrey L Cummings, Mihaela Levitchi Benea, et al.
Brain Pathology (Zurich, Switzerland)|January 7, 2026
Frontotemporal dementia: Clinical aspects, genetics, and neuropathology of a family with a C9ORF72 expansion in ArgentinaKaren Daniela Román, Carolina Agata Ardohain, Ezequiel I Surace, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2024
Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidanceLeanne Howard, Carla Abdelnour, Erin L Abner, et al.
Lupus|March 14, 2000
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusM Galeazzi, G D Sebastiani, A Tincani, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Etiologies of rapidly progressive dementias: A systematic review and meta-analysis of causes in worldwide and Latin AmericaJonathan Fernando Cubas Guillen, Carolina Agata Ardohain Cristalli, Waleska Berrios, et al.
Medicina|February 12, 2020
[Multidisciplinary rehabilitation for adult patients with stroke]Lucas Alessandro, Lisandro E Olmos, Lucas Bonamico, et al.
Pageof 19